|
|
Article: Bayer's CONTOUR and Bayer's BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology.
- Article from:
- Diabetes Week
- Article date:
- August 31, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The U. S. Food and Drug Administration issued Advice for Diabetic Patients and their Caregivers on August 13, stating that blood glucose meters that use GDH-PQQ technology may "produce a falsely high (elevated) blood glucose result." Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters (see also Diabetes Care).
Bayer Diabetes Care is committed to patient safety and has a portfolio of blood glucose meters that all meet the current FDA requirements. The company adheres to and supports the highest standard of quality in its meters ...